trending Market Intelligence /marketintelligence/en/news-insights/trending/oybogalyskj7ou0g7ntdng2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Apollo Endosurgery closes merger with Lpath

Streaming Media Devices Feel The Squeeze In Q3'19

AT&T To Use Wireless Subs To Create Buzz For HBO

Municipal CUSIP Requests On Pace For Record Year, Thanks To October Issuance Surge

Creating an Efficient Enterprise Wide Credit Risk Management System for a Leading Energy Company


Apollo Endosurgery closes merger with Lpath

Apollo Endosurgery Inc., a medical device company focused on less invasive therapies for the treatment of obesity, has completed its merger transaction with Lpath Inc.

Lpath was renamed Apollo Endosurgery Inc. after the closing of the deal and will start trading on the Nasdaq Global Market under the symbol APEN on Dec. 30.

Apollo's stockholders received common stock representing about 95.9% of the outstanding shares and the stockholders of Lpath retained about 4.1% of the combined company.

After a 1-for-5.5 reverse stock split, the combined company has about 10.7 million common shares outstanding.

Concurrent with the closing of the merger, certain stockholders of Apollo invested $29 million of new equity in the combined company, which is included in the 95.9% ownership of previous Apollo stockholders.